The FDA Listens. We Can Speak Up.

We can speak up.
FDA Listens.

FDA works better when they hear from patients. FDA wants to hear from us. They want to know how devices and medication work in real life.

FDA is big. So they have created processes to channel patient views […]

Anthem Responds to #DiabetesAccessMatters

media300x300actA DPAC Insider shared that Anthem, one of the companies receiving emails about the importance of access to prescribed diabetes treatments, has responded.

Dr. John S. Yao, M.D., M.P.H., F.A.C.P, the Staff VP Medical Policy Development, Office of Medical Policy […]

How to Tweet Your Way To Diabetes Advocacy Success

TweetTwitter has been described as a social media cocktail party. You can drift in and out of conversations, get news that matters to you, and raise your glass (and your voice) to those who inspire (or incense) you. For those […]

DPAC Insiders: The State of Diabetes Policy – 2nd Quarter 2016

 

DPAC Insiders Policy AdvocacyDo you know what the statuses are of the diabetes bills on Capitol Hill? What’s going to happen in this election year for diabetes policy? Are law makers even listening to the diabetes community?

Find out all of […]

National Institutes of Health (NIH) and Diabetes Advocacy

The DPAC Insider Perspective

What is the National Institutes of Health and why should you care about it?

Simple: this research agency helps people with diabetes.

19757410583_979ac94158_mHeadquartered in Bethesda, Maryland, it’s part of the U.S. Department of Health and Human Services. It’s […]

DPAC Insiders – 1st Quarter, 2016

DPAC Insider 600x300

Do you know that you can look back and forward at the same time? That’s what we’re doing with our DPAC Insiders quarterly dialogues. Our first was recently held and we shared what our diabetes policy advocacy community has done […]